Analog Devices, Inc. (ADI) filings document formal disclosures for a Massachusetts semiconductor issuer whose common stock trades on the Nasdaq Global Select Market. Recent 8-K reports furnish operating results, financial condition updates, dividend declarations, investor presentations under Regulation FD, and other material events tied to shareholder communications and capital return actions.
The company's proxy and shareholder-meeting filings cover director elections, board composition, committee assignments, executive compensation, shareholder voting results, and the Amended and Restated Analog Devices, Inc. 2020 Equity Incentive Plan. These records also describe governance procedures, equity-award matters, and the common-stock structure disclosed in Exchange Act filings.
Analog Devices Inc. insider Karen M. Golz filed a Form 144 indicating an intention to sell 1,000 shares of common stock through Fidelity Brokerage Services LLC on or after July 13, 2026 on the NASDAQ market. The planned sale is shown with an aggregate market value of $389,830.00.
The 1,000 shares proposed for sale were originally acquired from the issuer via restricted stock vesting as compensation on March 11, 2020. The filing also lists a prior sale in the last three months of 1,000 common shares on June 12, 2026 for an aggregate value of $411,950.00.
Analog Devices Inc. director Ray Stata reported open-market sales of 2,832 shares of common stock in early July 2026. The trades, executed over July 7–8, 2026 at prices between about $371 and $389 per share, were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 6, 2026.
Following these transactions, Stata directly holds 115,927 Analog Devices shares. He also reports indirect ownership of 652,221 shares held by his spouse. The filing shows multiple small sale lots, reflecting a structured disposition rather than a single large block trade.
Analog Devices Chair and CEO Vincent Roche reported an option exercise and share sale. On July 1, 2026, he exercised 10,000 Non-Qualified Stock Options at $108.08 per share, acquiring the same number of common shares.
On the same date, he completed an open-market sale of 10,000 common shares at an average price of $389.75 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 3, 2025. Following these transactions, Roche directly holds 137,537.875 common shares, with additional indirect holdings of 50,000 and 23,515 shares in separate Grantor Retained Annuity Trusts.
Analog Devices, Inc. entered into a new Revolving Credit Agreement providing a 364-day revolving credit facility with aggregate commitments of up to $3.0 billion. The facility initially expires on July 1, 2027, with potential one-year extensions on each annual anniversary, subject to lender consent.
The company may borrow, repay and reborrow amounts in multiple currencies, including U.S. dollars, euros and pounds sterling, and may designate certain foreign subsidiaries as additional borrowers, whose obligations it will guarantee. Interest may be based on Term SOFR plus a margin of 0.48%–0.925% or on a Base Rate, and a facility fee of 0.020%–0.075% applies on committed amounts.
The agreement includes customary covenants, events of default and limitations on liens and mergers. It also requires the company to maintain a consolidated EBITDA to consolidated interest coverage ratio of at least 3.00 to 1.00 starting with the first fiscal quarter ending after the closing date.
Vincent T. Roche submitted a Form 144 to sell 10,000 shares of Common Stock via a stock option exercise dated 07/01/2026, to be settled for cash.
The filing also lists multiple sales by Roche during the prior three months, including 30,000 shares on 05/22/2026 for $11,904,549 and 30,000 shares on 05/26/2026 for $12,453,855. The notice identifies the purchaser agent as Fidelity Brokerage Services LLC and the listing exchange as NASDAQ.
Analog Devices director Karen Golz reported an open-market sale of company stock. She sold 1,000 shares of common stock at a price of $411.95 per share. After this transaction, she directly holds 12,019 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026, indicating it was scheduled in advance rather than timed discretionarily.
Analog Devices director Ray Stata reported selling 1,416 shares of common stock on June 10, 2026, in multiple open-market transactions. The footnotes state these sales were made under a Rule 10b5-1 trading plan adopted on March 6, 2026, at weighted-average prices within ranges between about $392.55 and $409.07 per share. Following these transactions, Stata directly holds 118,759 shares and has an additional 652,221 shares reported as indirectly owned through his spouse.
Analog Devices director Ray Stata reported a planned stock sale. He sold 1,432 shares of common stock in 22 open-market transactions on June 9, 2026 at prices ranging from $383.89 to $413.755 per share, under a Rule 10b5-1 trading plan adopted on March 6, 2026. He also reports 652,221 shares held indirectly by his spouse.
Analog Devices insider sale reported. The filing reports Raymond S. Stata sold 3,125 shares of Common Stock on 03/10/2026 and another 3,125 shares on 03/11/2026. The proceeds shown are $1,000,396.88 and $995,521.25 for the respective trades.